Andreas Halvorsen: portfolio of Viking Global Investors

Andreas Halvorsen leads Viking Global Investors, a hedge fund that analyzes stocks worldwide and combines long and short positions.

Source: 13F filing with the US Securities and Exchange Commission dated Aug 14, 2019. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.

You are looking at Q2 2019. Go to the latest filing (Q3 2026)

22.3B USDQ2 2019
Total value of stock positions
22.3B USD
Positions
59
Share of the ten largest
54.0%

The ten largest positions Q2 2019

  1. Adaptive Biotechnologies Cor 8.3%new
  2. Amazon 6.8%▲ +157.6%
  3. Elevance Health 6.6%▼ −16.1%
  4. Meta Platforms 6.1%▲ +231.7%
  5. UnitedHealth Group 5.3%▲ +28.6%
  6. Microsoft 4.6%▼ −21.2%
  7. Boeing 4.5%new
  8. JD.com (ADR) 4.3%▲ +175.5%
  9. United Technologies Corp 3.9%▼ −4.8%
  10. Netflix 3.4%▲ +3.4%
Total value of stock positions per quarter, Q2 2013 to Q3 2026 (peak 38.5B USD).
Choose a quarter (54 filings)

All positions Q2 2019

Positions Q2 2019 per 13F filing, 22 of 22
Symbol Weight Shares Reported value Change Held since
ELV Elevance Health 6.6% 5,198,006 1.5B USD −16.1% reduced Q2 2017 9 quarters
MSFT Microsoft 4.6% 7,704,063 1.0B USD −21.2% reduced Q2 2016 13 quarters
United Technologies Corp 3.9% 6,743,903 878.1M USD −4.8% reduced Q3 2017 8 quarters
Liberty Media Corp Delaware 1.9% 11,379,423 425.7M USD −2.5% reduced Q1 2017 10 quarters
ADBE Adobe Inc. 1.6% 1,214,269 357.8M USD −40.5% reduced Q4 2018 3 quarters
ALGN Align Technology 1.4% 1,161,145 317.8M USD −35.3% reduced Q4 2018 3 quarters
GOOGL Alphabet Inc. (Class A) 1.4% 282,146 305.5M USD −24.7% reduced Q4 2015 15 quarters
Exact Sciences Corp 1.2% 2,264,674 267.3M USD −29.6% reduced Q3 2018 4 quarters
Biomarin Pharmaceutical Inc 1.0% 2,590,351 221.9M USD −49.5% reduced Q1 2018 6 quarters
NVDA Nvidia 0.6% 802,330 131.8M USD −57.4% reduced Q1 2019 2 quarters
GOOG Alphabet Inc. (Class C) 0.6% 114,172 123.4M USD −17.1% reduced Q4 2018 3 quarters
MRNA Moderna 0.5% 8,197,458 120.0M USD −50.8% reduced Q4 2018 3 quarters
Wellcare Health Plans Inc 0.5% 371,450 105.9M USD −71.9% reduced Q4 2018 3 quarters
BABA Alibaba Group (ADR) 0.4% 587,268 99.5M USD −89.8% reduced Q1 2018 6 quarters
Berry Global Group Inc 0.4% 1,804,817 94.9M USD −76.6% reduced Q3 2018 4 quarters
Syneos Health Inc 0.4% 1,796,775 91.8M USD −19.0% reduced Q1 2018 6 quarters
Covetrus Inc 0.4% 3,381,937 82.7M USD −13.1% reduced Q1 2019 2 quarters
V Visa Inc. 0.3% 387,368 67.2M USD −87.4% reduced Q3 2016 12 quarters
NXPI NXP Semiconductors 0.3% 670,065 65.4M USD −75.4% reduced Q1 2019 2 quarters
Blueprint Medicines Corp 0.2% 551,040 52.0M USD −16.3% reduced Q3 2018 4 quarters
Anaptysbio Inc 0.2% 799,897 45.1M USD −3.6% reduced Q1 2018 6 quarters
Eidos Therapeutics Inc 0.1% 882,353 27.4M USD −55.6% reduced Q2 2018 5 quarters

“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.

Breakdown by sector

  • Health Care 21.9%
  • Communication Services 11.5%
  • Technology 10.2%
  • Industrials 7.8%
  • Consumer Discretionary 7.4%
  • Consumer Staples 2.5%
  • Financials 2.2%
  • not in our coverage 36.4%

Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.

How to read this page

  • Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
  • Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
  • Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.

All superinvestor portfolios Screener: stocks held by superinvestors

↑ ↓ select · Enter open · Esc close